Gema Frühbeck Selected Research

Glycerol (Glycerine)

1/2020	Aquaporin-11 Contributes to TGF-β1-Induced Endoplasmic Reticulum Stress in Human Visceral Adipocytes: Role in Obesity-Associated Inflammation.
1/2018	Pancreatic Aquaporin-7: A Novel Target for Anti-diabetic Drugs?
1/2017	Physical exercise remodels visceral adipose tissue and mitochondrial lipid metabolism in rats fed a high-fat diet.
1/2017	Gastric Plication Improves Glycemia Partly by Restoring the Altered Expression of Aquaglyceroporins in Adipose Tissue and the Liver in Obese Rats.
9/2015	Sleeve Gastrectomy Reduces Hepatic Steatosis by Improving the Coordinated Regulation of Aquaglyceroporins in Adipose Tissue and Liver in Obese Rats.
7/2015	Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.
1/2015	Sexual Dimorphism of Adipose and Hepatic Aquaglyceroporins in Health and Metabolic Disorders.
11/2014	Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis.
1/2013	Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease.
6/2012	Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gema Frühbeck Research Topics

Disease

111	Obesity 01/2022 - 06/2002
53	Inflammation (Inflammations) 01/2022 - 08/2005
50	Insulin Resistance 05/2022 - 06/2002
49	Weight Loss (Weight Reduction) 07/2022 - 05/2004
36	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2006
22	Body Weight (Weight, Body) 09/2019 - 06/2002
16	Morbid Obesity 01/2022 - 03/2006
16	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2013
9	Fibrosis (Cirrhosis) 01/2022 - 01/2014
7	Neoplasms (Cancer) 07/2022 - 02/2010
7	Hypoxia (Hypoxemia) 08/2021 - 07/2008
6	Glucose Intolerance 01/2022 - 07/2011
6	Fatty Liver 01/2022 - 01/2013
6	Metabolic Diseases (Metabolic Disease) 01/2022 - 03/2013
5	Dyslipidemias (Dyslipidemia) 11/2021 - 11/2014
5	Hypertrophy 11/2019 - 04/2011
5	Anorexia Nervosa 11/2019 - 09/2015
5	Overweight 01/2019 - 06/2002
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2016
4	Weight Gain 01/2022 - 01/2017
4	Colonic Neoplasms (Colon Cancer) 08/2021 - 07/2011
4	Hyperglycemia 01/2021 - 04/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 08/2005
4	Hyperplasia 11/2019 - 10/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2007
3	Necrosis 10/2018 - 01/2008
3	Abdominal Obesity 01/2017 - 10/2008
3	Hypertension (High Blood Pressure) 03/2010 - 08/2006
2	Hyperinsulinism (Hyperinsulinemia) 06/2021 - 01/2018
2	COVID-19 01/2021 - 01/2021
2	Heart Failure 09/2017 - 03/2010
2	Feeding and Eating Disorders (Eating Disorder) 02/2016 - 01/2013
2	Wounds and Injuries (Trauma) 02/2016 - 02/2012
2	Diabetes Mellitus 08/2015 - 02/2009

Drug/Important Bio-Agent (IBA)

31	LeptinIBA 04/2021 - 06/2002
27	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2006
21	AdipokinesIBA 01/2021 - 01/2007
20	Messenger RNA (mRNA)IBA 01/2022 - 03/2006
20	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2002
14	LipidsIBA 01/2022 - 07/2007
14	Glycerol (Glycerine)FDA LinkGeneric 01/2020 - 07/2006
13	Insulin (Novolin)FDA Link 05/2022 - 07/2007
13	Triglycerides (Triacylglycerol)IBA 01/2019 - 07/2006
12	AdiponectinIBA 09/2019 - 11/2004
10	Hormones (Hormone)IBA 06/2021 - 06/2002
10	GhrelinIBA 11/2019 - 05/2004
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2010
9	OsteopontinIBA 01/2017 - 09/2007
8	CytokinesIBA 01/2022 - 11/2007
6	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2006
6	LipopolysaccharidesIBA 08/2021 - 11/2004
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2008
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 06/2009
5	Angiopoietin-Like Protein 8IBA 11/2021 - 10/2014
5	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2017
5	IronIBA 01/2018 - 01/2013
5	C-Reactive ProteinIBA 01/2017 - 06/2002
5	AquaglyceroporinsIBA 09/2015 - 04/2011
4	Biological ProductsIBA 01/2022 - 01/2004
4	Interleukin-18 (Interleukin 18)IBA 01/2021 - 07/2008
4	fibroblast growth factor 21IBA 01/2021 - 12/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2007
4	Peptides (Polypeptides)IBA 01/2019 - 04/2014
4	HDL CholesterolIBA 01/2018 - 01/2010
4	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2017 - 03/2006
3	Chemotactic FactorsIBA 01/2022 - 01/2011
3	Conditioned Culture MediaIBA 01/2022 - 01/2021
3	salicylhydroxamic acid (SHAM)IBA 11/2021 - 02/2012
3	InterleukinsIBA 08/2021 - 12/2016
3	InflammasomesIBA 01/2021 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2020 - 09/2012
3	OrexinsIBA 01/2019 - 03/2016
3	des-n-octanoyl ghrelinIBA 01/2019 - 03/2010
3	Heme (Haem)IBA 01/2018 - 01/2017
3	Lipocalin-2IBA 05/2015 - 07/2011
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2013 - 03/2006
2	Dietary Fats (Dietary Fat)IBA 01/2022 - 06/2021
2	NeuropeptidesIBA 06/2021 - 03/2012
2	EnzymesIBA 01/2020 - 01/2012
2	Pharmaceutical PreparationsIBA 03/2019 - 07/2006
2	Indicators and Reagents (Reagents)IBA 02/2019 - 10/2008
2	Aquaporins (Water Channels)IBA 01/2018 - 11/2005
2	metal transporting protein 1 (ferroportin)IBA 01/2018 - 04/2014
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2017 - 01/2017
2	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 01/2007
2	HDL LipoproteinsIBA 10/2016 - 09/2015
2	TenascinIBA 01/2016 - 10/2012
2	CaveolinsIBA 11/2014 - 07/2007
2	ResistinIBA 10/2014 - 08/2005
2	Ferritins (Ferritin)IBA 04/2014 - 01/2013
2	EndocannabinoidsIBA 01/2014 - 01/2013

Therapy/Procedure

29	Bariatric Surgery 01/2022 - 06/2002
18	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 05/2004
14	Gastrectomy 01/2022 - 10/2004
6	Therapeutics 06/2021 - 01/2016
5	Caloric Restriction 01/2022 - 09/2012
4	Operative Surgical Procedures 01/2018 - 05/2004
2	Precision Medicine 11/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
2	Obesity Management 01/2014 - 01/2013